Trial Profile
Efficacy and safety of Simeprevir/Sofosbuvir therapy in patients with chronic hepatitis C virus genotype IV infected egyptian patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2017
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 29 Dec 2017 New trial record